Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
From Hemoglobin Based Oxygen Carrier to Oxygen Therapeutics, Blood Substitutes, Nanomedicine and Artificial Cells Read chapter Read first chapter

2013 | OriginalPaper | Chapter

9. Regulatory Framework for Hemoglobin-Based Oxygen Carrier Trials

Author : Basil Golding

Published in: Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics

Publisher: Springer Berlin Heidelberg

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Oxygen therapeutics (OT) consist of hemoglobin-based oxygen carriers (HBOCs) and fluorocarbons. They have been developed to deliver oxygen (O2) to tissues, mainly for treatment of shock due to blood loss. These products are being developed in order to treat blood loss when red blood cells are not available, as may occur on the battlefield or in civilian life when trauma occurs.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now
previous chapter NIH/FDA/DOD Interagency Working Group on Oxygen Therapeutics
next chapter HBOCs from Chemical Modification of Hb
Literature
Buehler PW, Alayash AI (2008) All hemoglobin-based oxygen carriers are not created equally. Biochim Biophys Acta 1784(10):1378–81, Oct 2008, Epub 3 Jan. 2008
Buehler PW, D’Agnillo F, Schaer DJ (2010) Hemoglobin-based oxygen carriers: from mechanisms of toxicity and clearance to rational drug design. Trends Mol Med. 16(10):447–57, 2010, Epub 13 Aug 2010
Chen JY, Scerbo M, Kramer G (2009) A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. CLINICS 64(8):803–813CrossRef
Guidance for Industry (2004) Criteria for safety and efficacy evaluation of oxygen therapeutics as red blood cell substitutes, Draft Guidance, Oct 2004
Guidance for Industry (2008) CGMP for Phase 1 investigational drugs, July 2008
Guidance for Industry (2010) Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by blood and blood products
Guidance for Institutional Review Boards (2011) Clinical Investigators, and Sponsors Exception from Informed Consent Requirements for Emergency Research. U.S. Department of Health and Human Services Food and Drug Administration Office of Good Clinical Practice Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Center for Devices and Radiological Health March 2011
Guideline for Good Clinical Practice (2002) ICH E6, July 2002
ICH Harmonised Tripartite Guideline Preclinical Safety Evaluation Of Biotechnology-Derived Pharmaceuticals S6(R1) 2008, Parent Guideline dated 16 July 1997, Current Step 4 version Addendum dated 12 June 2011 incorporated at the end of June 2011
ICH Topic E 8 (1998) General Considerations for Clinical Trials, March, 1998
ICH Topic Q 5 A (R1) (2000) Quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin
Jahr JS, Akha AS, Holtby RJ (2012) Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: Clinical safety and efficacy of recent and current products. Current drug discovery technologies, Bentham Science Publishers, 9, p 158–165, 1875– 6220/12
Kazmierczak SC, Catrou PG, Boudreau D (1998) Simplified interpretative format for assessing test interference: studies with hemoglobin-based oxygen carrier solutions. Clin Chem 44:2347–2352
Meredith JW, Kilgo PD, Osler T (2003) A fresh set of survival risk ratios derived from incidents in the National Trauma Data Bank from which the ICISS may be calculated. J Trauma 55(5):924–932CrossRef
Monnet X, Teboul JL (2010) Early fluid resuscitation, Current Infect Dis Rep 12(5):354–360,
Yücel N, Lefering R, Maegele M, Vorweg M, Tjardes T, Ruchholtz S, Neugebauer EA, Wappler F, Bouillon B, Rixen D (2006) Polytrauma study group of the german trauma society trauma associated severe hemorrhage (TASH)-score: probability of mass ransfusion as surrogate for life threatening hemorrhage after multiple trauma, J Trauma 60(6):1228–1236, 2006 (discussion 1236–1237)
Metadata
Title
Regulatory Framework for Hemoglobin-Based Oxygen Carrier Trials
Author
Basil Golding
Copyright Year
2013
Publisher
Springer Berlin Heidelberg
Book
Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics

Print ISBN: 978-3-642-40716-1

Electronic ISBN: 978-3-642-40717-8

Copyright Year: 2013

DOI
https://doi.org/10.1007/978-3-642-40717-8_9

Premium Partners

    Image Credits